The authors reply

New England Journal of Medicine

Volumn 367, Issue 9, 2012, Pages 875-876

  Davies, Michael J ^a   Moore, Vivienne M ^a   Haan, Eric A ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SA PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE;

BIRTH DEFECT; FEMALE INFERTILITY; FERTILIZATION IN VITRO; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LETTER; MULTIPLE PREGNANCY; PATERNAL AGE; PRIORITY JOURNAL;

EID: 84865484063     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1206859     Document Type: Letter

References (5)

1. Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted reproductive technologies and the risk of birth defects - a systematic review. Hum Reprod 2005;20:328-38.
2. Marino JL, Moore VM, Rumbold AR, Davies MJ. Fertility treatments and the young women who use them: an Australian cohort study. Hum Reprod 2011;26:473-9.
3. Green RF, Devine O, Crider KS, et al. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol 2010;20:241-9.
4. Yang Q, Wen SW, Leader A, Chen XK, Lipson J, Walker M. Paternal age and birth defects: how strong is the association? Hum Reprod 2007;22:696-701.
5. Kazaura M, Lie RT, Skjaerven R. Paternal age and the risk of birth defects in Norway. Ann Epidemiol 2004;14:566-70.